{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:59:49Z","timestamp":1791053989529,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.joms.2013.11.005","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T13:00:41Z","timestamp":1385038841000},"page":"903-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Is Bone Turnover of Jawbone and Its Possible Over Suppression by Bisphosphonates of Etiologic Importance in Pathogenesis of Bisphosphonate-Related Osteonecrosis?"],"prefix":"10.1016","volume":"72","author":[{"given":"Oliver","family":"Ristow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gerngro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hohlweg-Majert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Hahnefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Pautke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2013.11.005_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib3","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2013.11.005_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00784-012-0873-3","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment\u2014A grossly underestimated risk?","volume":"17","author":"Hansen","year":"2013","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2013.11.005_bib6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.joms.2013.11.005_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2013.11.005_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1159\/000343950","article-title":"Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation","volume":"35","author":"Then","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.joms.2013.11.005_bib9","series-title":"Bridging the Gap Between Dental & Orthopaedic Implants","article-title":"Remodeling of bone surrounding the implant interface","author":"Garetto","year":"1998"},{"key":"10.1016\/j.joms.2013.11.005_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ar.a.20396","article-title":"Remodeling dynamics in the alveolar process in skeletally mature dogs","volume":"288","author":"Huja","year":"2006","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"10.1016\/j.joms.2013.11.005_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00774-007-0837-x","article-title":"Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat","volume":"26","author":"Bauss","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.joms.2013.11.005_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ar.1091960210","article-title":"Dynamic histomorphometry of alveolar bone remodeling in the adult rat","volume":"196","author":"Vignery","year":"1980","journal-title":"Anat Rec"},{"key":"10.1016\/j.joms.2013.11.005_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","article-title":"Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells","volume":"14","author":"Walter","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.joms.2013.11.005_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1359\/jbmr.1997.12.4.498","article-title":"Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss","volume":"12","author":"Han","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2013.11.005_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3816\/CBC.2010.n.004","article-title":"Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results","volume":"10","author":"Morris","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.joms.2013.11.005_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.oraloncology.2010.01.001","article-title":"Scintigraphic evaluation of mandibular bone turnover in patients with solid tumors receiving zoledronic acid","volume":"46","author":"Van den Wyngaert","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2013.11.005_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.joms.2013.11.005_bib18","first-page":"1765","article-title":"A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index","volume":"4","author":"Imbriaco","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2013.11.005_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00006231-199201000-00010","article-title":"A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: Quantitative measurement of radioactivity in global skeletal regions of interest","volume":"13","author":"D'Addabbo","year":"1992","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.joms.2013.11.005_bib20","first-page":"815","article-title":"Age-related change of technetium-99 m-HMDP distribution in the skeleton","volume":"37","author":"Kigami","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.joms.2010.05.062","article-title":"Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs","volume":"69","author":"Huja","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcb.21983","article-title":"Inhibition of osteoblast function in\u00a0vitro by amino bisphosphonates","volume":"106","author":"Orriss","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.joms.2013.11.005_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates\u2014Histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2013.11.005_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","article-title":"Peripheral blood monocytes are responsible for gamma,delta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP","volume":"144","author":"Roelofs","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.joms.2013.11.005_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib27","first-page":"1165","article-title":"The effect of zoledronic acid on the function and differentiation of myeloid cells","volume":"91","author":"Wolf","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.joms.2013.11.005_bib28","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1902\/jop.2008.080041","article-title":"Effects of risedronate on alveolar bone loss and angiogenesis: A stereologic study in rats","volume":"79","author":"Cetinkaya","year":"2008","journal-title":"J Periodontol"},{"key":"10.1016\/j.joms.2013.11.005_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1359\/jbmr.2002.17.6.998","article-title":"Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice","volume":"17","author":"Deckers","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2013.11.005_bib30","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1535-7163.MCT-07-0311","article-title":"Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma","volume":"6","author":"Scavelli","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.joms.2013.11.005_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.joms.2013.11.005_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib34","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2013.11.005_bib35","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: Effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.joms.2013.11.005_bib38","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib39","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.4317\/medoral.17583","article-title":"Study of serum CTX in 50 oral surgical patients treated with oral bisphosphonates","volume":"17","author":"Flichy-Fernandez","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2013.11.005_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2967\/jnumed.107.048595","article-title":"Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling","volume":"49","author":"Moore","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/RLU.0b013e31827082f0","article-title":"Role of nuclear medicine imaging in recognizing different causes of osteonecrosis of the jaw","volume":"38","author":"Joshi","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib42","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.oooo.2012.09.006","article-title":"Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw","volume":"115","author":"Ohbayashi","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2013.11.005_bib43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/RLU.0b013e31825b2430","article-title":"Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw: Is there something missing?","volume":"37","author":"Hakim","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/RLU.0b013e3181feeb72","article-title":"Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw","volume":"36","author":"Van den Wyngaert","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"\u201cBis-phossy jaws\u201d\u2014High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014Characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2013.11.005_bib47","first-page":"845","article-title":"Bone scan in dental diseases","volume":"19","author":"Tow","year":"1978","journal-title":"J Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0001-2998(97)80049-9","article-title":"Abnormal skull uptake on bone scan","volume":"27","author":"Ackerman","year":"1997","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.joms.2013.11.005_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239113014158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239113014158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:43:16Z","timestamp":1759509796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239113014158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0278239113014158"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2013.11.005","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Bone Turnover of Jawbone and Its Possible Over Suppression by Bisphosphonates of Etiologic Importance in Pathogenesis of Bisphosphonate-Related Osteonecrosis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2013.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}